Staphefekt
Channel:
Subscribers:
9,560
Published on ● Video Link: https://www.youtube.com/watch?v=0iPIH5aGtSI
0Staphefekt is a proprietary enzyme (an endolysin) intended to treat Staphylococcus aureus skin infections in humans. It is developed and produced by the Dutch biotechnology company Micreos. It became the first commercially available endolysin and is marketed in Gladskin products.The enzyme has been shown to be effective in killing S. aureus strains resistant to antibiotics such as MRSA. The enzyme has successfully been used for treatment of S. aureus-related dermatosis.
Source: https://en.wikipedia.org/wiki/Staphefekt
Created with WikipediaReaderReborn (c) WikipediaReader
Other Videos By WikiReader
| 2021-09-23 | Kypria |
| 2021-09-23 | Panegyra flavicostana |
| 2021-09-23 | Granges-sur-Lot |
| 2021-09-23 | Invergarry Castle |
| 2021-09-23 | Cape Hoppner |
| 2021-09-23 | Alessandro Borgese |
| 2021-09-23 | Sibnica (Rekovac) |
| 2021-09-23 | Perch SSSI |
| 2021-09-23 | Yala Peak |
| 2021-09-23 | Trismelasmos drago |
| 2021-09-23 | Staphefekt |
| 2021-09-23 | Chamber of Deputies of Chile |
| 2021-09-23 | Mauger of Hauteville |
| 2021-09-23 | Sutton School |
| 2021-09-23 | A Winter Romance |
| 2021-09-23 | ZNF19 |
| 2021-09-23 | Bombing of Braunschweig (October 1944) |
| 2021-09-23 | List of Major League Baseball players (La–Lh) |
| 2021-09-23 | Hester Sondergaard |
| 2021-09-23 | 2011 European Athletics U23 Championships – Men's high jump |
| 2021-09-23 | Split Rock River |
Tags:
Antibiotic
Antibiotics
Dermatosis
Doiidentifier
Enzyme
Lysin
MethicillinresistantStaphylococcusaureus
Micreos